These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 5431557)

  • 21. Haloprogin and nystatin therapy for cutaneous candidiasis. Comparison of the efficacy of haloprogin and nystatin therapy.
    Carter VH; Olansky S
    Arch Dermatol; 1974 Jul; 110(1):81-2. PubMed ID: 4608934
    [No Abstract]   [Full Text] [Related]  

  • 22. Dermatophytosis: an approach to therapy.
    Skinner RB; Reece R; Hernandez AD
    Compr Ther; 1984 Jun; 10(6):37-40. PubMed ID: 6734132
    [No Abstract]   [Full Text] [Related]  

  • 23. Clinical efficacy studies of haloprogin, a new topical antimicrobial agent.
    Hermann HW
    Arch Dermatol; 1972 Dec; 106(6):839-42. PubMed ID: 4565229
    [No Abstract]   [Full Text] [Related]  

  • 24. [Antimycotic agents for external treatment of dermatomycoses].
    Scherwitz C; Meinhof W
    Hautarzt; 1974 Oct; 25(10):463-70. PubMed ID: 4448631
    [No Abstract]   [Full Text] [Related]  

  • 25. [Clinical experiences with new antifungal agents: 2-aminotridecan-undecylenate (VUFB 7477) and 2-aminotridecan-2-chloro-4-nitrophenolate (VUFB 8115)].
    Klĩma J
    Cesk Dermatol; 1972 Dec; 47(6):252-5. PubMed ID: 4576921
    [No Abstract]   [Full Text] [Related]  

  • 26. New topical agents for dermatophytosis.
    Smith EB
    Cutis; 1976 Jan; 17(1):54-8. PubMed ID: 1037098
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dermatophyte infections.
    Clayton YM
    Postgrad Med J; 1979 Sep; 55(647):605-7. PubMed ID: 392476
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Treatment of superficial mycoses].
    Feuilhade de Chauvin M; Touraine R
    Rev Prat; 1984 Feb; 34(7):313-20. PubMed ID: 6322279
    [No Abstract]   [Full Text] [Related]  

  • 29. [Multicenter evaluation of the activity and tolerance of a new antimycotic agent: ciclopiroxolamine].
    Cattaneo M; Betti R; Lodi A; Masnada MC
    G Ital Dermatol Venereol; 1986; 121(6):LXXXI-LXXXV. PubMed ID: 3557531
    [No Abstract]   [Full Text] [Related]  

  • 30. [Use of Nitrofungin in the therapy of dermatomycoses].
    Danilov LN
    Cesk Dermatol; 1973 Aug; 48(4):245-6. PubMed ID: 4727830
    [No Abstract]   [Full Text] [Related]  

  • 31. Screening test method for the determination of the in vitro activity of topical antimycotics.
    Gip L; Gip C
    Mykosen; 1984 Jul; 27(7):348-54. PubMed ID: 6482898
    [No Abstract]   [Full Text] [Related]  

  • 32. [Mycosis of the feet: therapy].
    Beurey J; Weber M; Mougeolle JM
    Phlebologie; 1969; 22(1):83-90. PubMed ID: 5775651
    [No Abstract]   [Full Text] [Related]  

  • 33. A comparative trial of chlorphenesin and pecilocin in a prison community.
    Harris C; Philpot CM
    Br J Clin Pract; 1969 Nov; 23(11):449-51. PubMed ID: 4900295
    [No Abstract]   [Full Text] [Related]  

  • 34. Establishment and treatment of cutaneous Candida albicans infection in the rabbit.
    Maestrone G; Semar R
    Naturwissenschaften; 1968 Feb; 55(2):87-8. PubMed ID: 5703113
    [No Abstract]   [Full Text] [Related]  

  • 35. [Nystatin ointment in the therapy of rhagades of the breast in wet nurses].
    Mariggiò A
    Minerva Pediatr; 1979 Dec; 31(23):1733-4. PubMed ID: 554965
    [No Abstract]   [Full Text] [Related]  

  • 36. [1% tioconazole powder in the treatment of dermatomycoses].
    Tulli A; Leone E; De Simone C
    Clin Ter; 1988 Sep; 126(6):417-20. PubMed ID: 2974403
    [No Abstract]   [Full Text] [Related]  

  • 37. Guidelines for treatment of onychomycosis.
    Roberts DT; Taylor WD; Boyle J;
    Br J Dermatol; 2003 Mar; 148(3):402-10. PubMed ID: 12653730
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Superficial mycoses: a strategic approach.
    Rao A; Forgan-Smith R
    Med J Aust; 1993 Apr; 158(7):476-7. PubMed ID: 8469198
    [No Abstract]   [Full Text] [Related]  

  • 39. [Experiences with tinea pedis in daily practice].
    Janke D
    Arch Klin Exp Dermatol; 1966; 227(1):564-8. PubMed ID: 4383352
    [No Abstract]   [Full Text] [Related]  

  • 40. [Evaluation of the clinical efficacy and tolerance of a formulation of 2% tioconazole cream versus 1% tioconazole cream in the treatment of dermatomycoses].
    Tulli A
    G Ital Chemioter; 1988; 35(1-3):69-73. PubMed ID: 3256513
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.